Journal of the American College of Clinical Pharmacy : JACCP最新文献

A tale of two bills: Lessons learned in expanding pharmacist-led HIV pre-exposure and post-exposure prophylaxis 两份账单的故事：在扩大由药剂师主导的艾滋病暴露前和暴露后预防工作中吸取的经验教训

IF 1.3

Journal of the American College of Clinical Pharmacy : JACCP Pub Date : 2024-10-08 DOI: 10.1002/jac5.2027

Jennifer Cocohoba Pharm.D., MAS, Jerika Lam Pharm.D., Maria Lopez Pharm.D., Betty J. Dong Pharm.D.

引用次数: 0

Serving as a professional association board member: Benefits to leaders and their employers 担任专业协会理事会成员：对领导者及其雇主的益处

IF 1.3

Journal of the American College of Clinical Pharmacy : JACCP Pub Date : 2024-09-24 DOI: 10.1002/jac5.2026

Brian L. Erstad Pharm.D., FCCP, Judith Jacobi Pharm.D., FCCP, William A. Kehoe Pharm.D., M.A., FCCP, Suzanne A. Nesbit Pharm.D., FCCP, Terry L. Seaton Pharm.D., FCCP

{"title":"Serving as a professional association board member: Benefits to leaders and their employers","authors":"Brian L. Erstad Pharm.D., FCCP, Judith Jacobi Pharm.D., FCCP, William A. Kehoe Pharm.D., M.A., FCCP, Suzanne A. Nesbit Pharm.D., FCCP, Terry L. Seaton Pharm.D., FCCP","doi":"10.1002/jac5.2026","DOIUrl":"https://doi.org/10.1002/jac5.2026","url":null,"abstract":"This commentary, written by past presidents of the American College of Clinical Pharmacy, highlights the benefits of serving in leadership roles within professional associations to the leaders themselves, their employers, their colleagues, and the broader profession. Fostering the development of leaders is a necessary step to advance pharmacy's future. Leaders benefit not only from the reinvigoration and personal growth associated with their service effort but also from the further development of skills such as collaboration and consensus-building, written and oral communication, critical thinking, leadership, and time management. The honing of these skills has benefits at the leader's workplace. Colleagues in businesses outside health care view this type of leadership experience as external training to develop and refine organizational communication and leadership skills and better prepare their employees for the future. The leader also learns best practices and new perspectives that, when shared locally, can energize the employer organization. Beyond the benefits to the leader and the leader's employer, there are holistic benefits of association service to the profession and interprofessional teams. With this in mind, we suggest that employers welcome opportunities to have their coworkers serve in elected or appointed positions within professional associations.","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142430164","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Unique model for pharmacist cross-coverage in the ambulatory care setting 流动医疗机构药剂师交叉覆盖的独特模式

IF 1.3

Journal of the American College of Clinical Pharmacy : JACCP Pub Date : 2024-09-16 DOI: 10.1002/jac5.2025

Anna Abrahamson Pharm.D., Shelby Tungate Lopez Pharm.D., Zack Deyo Pharm.D.

{"title":"Unique model for pharmacist cross-coverage in the ambulatory care setting","authors":"Anna Abrahamson Pharm.D., Shelby Tungate Lopez Pharm.D., Zack Deyo Pharm.D.","doi":"10.1002/jac5.2025","DOIUrl":"https://doi.org/10.1002/jac5.2025","url":null,"abstract":"Clinical cross-coverage in ambulatory care pharmacy practice is currently lacking and can lead to gaps in patient care, lost revenue generation, and pharmacist burnout due to a lack of time and support for indirect patient care and non-clinical activities. To address this need, a cross-coverage model for a team of ambulatory care pharmacists practicing in diverse clinical settings was developed and is primarily supported by a single broadly-trained pharmacist known as an ambulatory care generalist. Cross-coverage from the ambulatory care generalist includes in-person and virtual patient care as well as in-basket management and is available to all clinic-based pharmacists on the specialty and primary care team with a few select clinics involving a designated collaborative practice agreement. The cross-covering pharmacist has been shown to positively impact productivity measures and components of pharmacist burnout. Widespread implementation of this cross-coverage model has the potential to greatly impact pharmacy practice and patient care in the ambulatory care setting and increase sources of revenue.","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142430076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Part II: Recorded webcast: Vaping 第二部分：网络广播录音：吸烟

IF 1.3

Journal of the American College of Clinical Pharmacy : JACCP Pub Date : 2024-09-10 DOI: 10.1002/jac5.2018

Chasity M. Shelton Pharm.D., FCCP

引用次数: 0

Connecting medication therapy problems with social determinants of health: A proposed framework 将药物治疗问题与健康的社会决定因素联系起来：拟议框架

IF 1.3

Journal of the American College of Clinical Pharmacy : JACCP Pub Date : 2024-09-10 DOI: 10.1002/jac5.2016

Kylee A. Funk Pharm.D., Lindsay A. Sorge Pharm.D., Deborah L. Pestka Pharm.D., Ph.D.

引用次数: 0

Collaborative leadership exists within all our scopes of practice 在我们的所有业务范围内都存在合作领导力

IF 1.3

Journal of the American College of Clinical Pharmacy : JACCP Pub Date : 2024-09-10 DOI: 10.1002/jac5.2017

Rosalyn Padiyara Vellurattil Pharm.D., Rebecca M. Singer DNP

引用次数: 0

Part I: Case series: Pancreatitis 第一部分：病例系列：胰腺炎

IF 1.3

Journal of the American College of Clinical Pharmacy : JACCP Pub Date : 2024-09-10 DOI: 10.1002/jac5.2019

Abigail M. Yancey Pharm.D., FCCP

引用次数: 0

Interprofessional team-based care in the community pharmacy setting: A summary of existing models and best practice recommendations 社区药房环境中的跨专业团队护理：现有模式总结和最佳实践建议

IF 1.3

Journal of the American College of Clinical Pharmacy : JACCP Pub Date : 2024-09-03 DOI: 10.1002/jac5.2021

Adriane N. Irwin Pharm.D., M.S., FCCP, Macary Weck Marciniak Pharm.D., Reham Awad Pharm.D., Christine L. Cadiz Pharm.D., M.A., Sarah Grace Cook Pharm.D., Sophia M. C. Herbert Pharm.D., Joyce Y. Lee Pharm.D., FCCP, Lucas E. Orth Pharm.D., Jennifer A. Szwak Pharm.D., FCCP

{"title":"Interprofessional team-based care in the community pharmacy setting: A summary of existing models and best practice recommendations","authors":"Adriane N. Irwin Pharm.D., M.S., FCCP, Macary Weck Marciniak Pharm.D., Reham Awad Pharm.D., Christine L. Cadiz Pharm.D., M.A., Sarah Grace Cook Pharm.D., Sophia M. C. Herbert Pharm.D., Joyce Y. Lee Pharm.D., FCCP, Lucas E. Orth Pharm.D., Jennifer A. Szwak Pharm.D., FCCP","doi":"10.1002/jac5.2021","DOIUrl":"https://doi.org/10.1002/jac5.2021","url":null,"abstract":"Community pharmacies are rapidly becoming destinations for health services beyond medication dispensing. Delivery models for community-based services have become increasingly complex, creating expanded opportunities and necessitating collaboration between pharmacists in the community setting and other health care professionals. As a result, it is essential to articulate best practices and recommendations to assist stakeholders in responding to the changing landscape and optimize care for patients. This white paper provides a summary of published examples of interprofessional practice that include community pharmacies in the United States and internationally, and then adapts established guiding principles for interprofessional practice to the community pharmacy setting to outline a framework and specific recommendations for consideration. This framework highlights a need to place patients at the center of collaborative community-based care models, have organizational leaders show a commitment to and establish an infrastructure for interprofessional collaboration that includes community-based pharmacists, foster respect for community pharmacy practice, address communication and technology barriers in the health care system, and finally, embrace interprofessional learning in the community pharmacy setting. Addressing challenges and embracing opportunities is vital to accelerate practice transformation and further position community-based pharmacists as essential members of interprofessional care teams.","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142428950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Creation of a novel vancomycin dosing protocol in the electronic medical record and the use of analytics to show improved patient safety 在电子病历中创建新颖的万古霉素用药方案，并利用分析技术显示患者安全得到了改善

IF 1.3

Journal of the American College of Clinical Pharmacy : JACCP Pub Date : 2024-09-02 DOI: 10.1002/jac5.2023

Nathan Peterson Pharm.D., Evan Hurley Pharm.D., Kelli Cunningham Pharm.D., Luke Malik Pharm.D., Lisa Lambi Pharm.D., Kristina White Pharm.D., Amanda Bushman Pharm.D., Julia Fifield Pharm.D., Corey Thieman Pharm.D., Emily Muehling Pharm.D.

{"title":"Creation of a novel vancomycin dosing protocol in the electronic medical record and the use of analytics to show improved patient safety","authors":"Nathan Peterson Pharm.D., Evan Hurley Pharm.D., Kelli Cunningham Pharm.D., Luke Malik Pharm.D., Lisa Lambi Pharm.D., Kristina White Pharm.D., Amanda Bushman Pharm.D., Julia Fifield Pharm.D., Corey Thieman Pharm.D., Emily Muehling Pharm.D.","doi":"10.1002/jac5.2023","DOIUrl":"https://doi.org/10.1002/jac5.2023","url":null,"abstract":"Vancomycin dosing guidelines recommend using first-order analytic calculations or Bayesian software along with two drug concentrations at steady state to confirm an area under the serum concentration versus time curve (AUC24), which is safe and efficacious for the treatment of serious methicillin-resistant Staphylococcus aureus (MRSA) infections. Evidence supporting optimal vancomycin dosing for empiric or nonserious MRSA infections is sparse. A systemwide vancomycin dosing protocol applying the latest guidelines and a novel dosing strategy to estimate AUC was created by a large, multicenter healthcare organization. A dosing calculator was embedded in the electronic medical record, and an analytics tool was created to monitor the incidence and predictors of vancomycin-associated acute kidney injury (VA-AKI). The incidence of VA-AKI was tracked over time and between hospitals to identify opportunities to reduce variation. This article describes the implementation of the vancomycin protocol and the use of informatics to ensure patient safety.","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142428876","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Falling pass rates on the North American Pharmacist Licensure Examination signal an emerging crisis for a growing number of pharmacy schools 北美药剂师执业资格考试通过率下降预示着越来越多的药学院面临新的危机

IF 1.3

Journal of the American College of Clinical Pharmacy : JACCP Pub Date : 2024-08-05 DOI: 10.1002/jac5.2015

Daniel L. Brown Pharm.D.

{"title":"Falling pass rates on the North American Pharmacist Licensure Examination signal an emerging crisis for a growing number of pharmacy schools","authors":"Daniel L. Brown Pharm.D.","doi":"10.1002/jac5.2015","DOIUrl":"https://doi.org/10.1002/jac5.2015","url":null,"abstract":"The North American Pharmacist Licensure Examination (NAPLEX) is a major assessment metric for graduates pursuing licensure and the institutions from which they graduated. Before 2014, the mean NAPLEX first-time pass rate was roughly 95% every year. Mean pass rates have fallen dramatically since then to less than 80%, with many schools currently unable to achieve a 70% pass rate. Such a drastic decline in NAPLEX performance constitutes a crisis for many schools. Changes to the exam blueprint, administration, and scoring provide a partial explanation for the decline, but the issue of cause ultimately comes down to one simple question: What has changed over the last 10 years that is making it more difficult for graduates to pass NAPLEX on the first attempt? The effects of excessive academic expansion, beginning in 2000, cannot be overlooked. The newest schools, established after 2009, and accelerated (3-year) programs, many of which are also new, appear to be particularly vulnerable. In 2023, 16 pharmacy schools had first-time pass rates below 65%. Nine (56%) of those schools opened after 2009 and seven (44%) were accelerated programs. Newer schools have had to compete for a limited supply of qualified faculty, administrators, preceptors and experiential training sites, while also striving to meet enrollment targets amid a dwindling applicant pool. The ability to overcome the NAPLEX crisis depends on first establishing a more effective process of assessing NAPLEX results—one that measures the right metrics in the right way—and upholds fair, but rigorous, quality standards. Stakeholders need access to actionable information and the most relevant, useful data available. The purpose of this article is to provide evidence that the Academy is facing a legitimate crisis and offer four recommendations by which assessment and understanding of the crisis can be enhanced.","PeriodicalId":73966,"journal":{"name":"Journal of the American College of Clinical Pharmacy : JACCP","volume":null,"pages":null},"PeriodicalIF":1.3,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142429430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0